Meta-analysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

A. Singal, M. L. Volk, A. Waljee, R. Salgia, P. Higgins, M. A M Rogers, J. A. Marrero

Research output: Contribution to journalArticle

380 Citations (Scopus)

Abstract

Background A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. Aim To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria. Methods A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC. Results Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94%. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63%. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality. Conclusions Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.

Original languageEnglish (US)
Pages (from-to)37-47
Number of pages11
JournalAlimentary Pharmacology and Therapeutics
Volume30
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Meta-Analysis
Hepatocellular Carcinoma
Fibrosis
alpha-Fetoproteins
MEDLINE
Regression Analysis
Databases
Neoplasms

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Meta-analysis : Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. / Singal, A.; Volk, M. L.; Waljee, A.; Salgia, R.; Higgins, P.; Rogers, M. A M; Marrero, J. A.

In: Alimentary Pharmacology and Therapeutics, Vol. 30, No. 1, 07.2009, p. 37-47.

Research output: Contribution to journalArticle

@article{55a6859f67334fa59f4df7c0a529386c,
title = "Meta-analysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis",
abstract = "Background A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. Aim To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria. Methods A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC. Results Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94{\%}. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63{\%}. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality. Conclusions Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.",
author = "A. Singal and Volk, {M. L.} and A. Waljee and R. Salgia and P. Higgins and Rogers, {M. A M} and Marrero, {J. A.}",
year = "2009",
month = "7",
doi = "10.1111/j.1365-2036.2009.04014.x",
language = "English (US)",
volume = "30",
pages = "37--47",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Meta-analysis

T2 - Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

AU - Singal, A.

AU - Volk, M. L.

AU - Waljee, A.

AU - Salgia, R.

AU - Higgins, P.

AU - Rogers, M. A M

AU - Marrero, J. A.

PY - 2009/7

Y1 - 2009/7

N2 - Background A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. Aim To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria. Methods A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC. Results Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94%. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63%. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality. Conclusions Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.

AB - Background A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. Aim To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria. Methods A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC. Results Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94%. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63%. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality. Conclusions Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.

UR - http://www.scopus.com/inward/record.url?scp=67449107459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449107459&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2009.04014.x

DO - 10.1111/j.1365-2036.2009.04014.x

M3 - Article

C2 - 19392863

AN - SCOPUS:67449107459

VL - 30

SP - 37

EP - 47

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 1

ER -